Efficacy and safety of pravastatin vs simvastatin after cardiac transplantation
- 1 June 2000
- journal article
- clinical trial
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 19 (6), 529-537
- https://doi.org/10.1016/s1053-2498(00)00077-2
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Metabolism and Drug Interactions of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors in Transplant Patients: Are the Statins Mechanistically Similar?Pharmacology & Therapeutics, 1998
- Accumulation of lovastatin, but not pravastatin, in the blood of cyclosporine-treated kidney graft patients after multiple doses*Clinical Pharmacology & Therapeutics, 1997
- Simvastatin Reduces Graft Vessel Disease and Mortality After Heart TransplantationCirculation, 1997
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Effect of Pravastatin on Outcomes after Cardiac TransplantationNew England Journal of Medicine, 1995
- SAFETY AND EFFICACY OF LOW DOSE SIMVASTATIN IN CARDIAC TRANSPLANT RECIPIENTS TREATED WITH CYCLOSPORINETransplantation, 1994
- The Australian and New Zealand Cardiothoracic Organ Transplant Registry: first report 1984ndash;1992Australian and New Zealand Journal of Medicine, 1992
- Long-Term Clinical Tolerance of Lovastatin and SimvastatinJMIR AI, 1990